we have studied the plasma pharmacokinetics of idarubicin ( 4-demethoxy-daunorubicin ) in eight leukemia patients receiving five daily i.v . injections ( 7-9 mg/m2 per day ) of this new anthracycline .
C0020789
idarubicin
C0011015
daunorubicin